Twist Bioscience posted 23% year-over-year sales growth and beat EPS expectations in its most recent quarter. Click here to ...

The global Oligonucleotide Synthesis Market is valued at USD 7.78 Billion in 2024 and is projected to reach a value of USD 21 ...

The global gene synthesis market is estimated to be valued at USD 1,089.3 million in 2025 and is projected to reach USD 6,203.6 million by 2035, registering a compound annual growth rate of 19% over ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

Giving scientists direct control over DNA and mRNA synthesis timelines is a game changer, enabling high-fidelity genes and mRNA constructs to be built overnight, on demand, and right in the lab.

"DNA synthesis is a core technology for synthetic biology and we're happy to combine some of our long DNA technology with Twist to hopefully see more and varied offerings in the market," said Jason ...

As credit against the agreement signed in 2022, Twist receives licenses and assignments for certain long DNA and other technology as well as related reagents to complement its existing DNA synthesis ...